Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Clinical Trials
3 recruiting trials for Pathologic Stage IIIC Cutaneous Melanoma AJCC v8. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 1NCT04119024
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic...
This phase I trial studies the side effects and best dose of modified immune cells (IL13Ralpha2 CAR T cells) after a chemotherapy conditioning regimen for the treatment of...
Sponsor: Anusha KalbasiEnrolling: 183 locations
RECRUITINGPhase 1NCT05039801
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
To find the highest tolerable dose of IACS-6274 that can be given alone, in combination with bevacizumab and paclitaxel, or in combination with capivasertib to patients who have...
Sponsor: M.D. Anderson Cancer CenterEnrolling: 541 location
RECRUITINGNCT07259304
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
This study assesses how personal relationships (such as friendships, family relationships, or romantic partners) influence the physical activity (exercise) and well-being of young...
Sponsor: University of Southern CaliforniaEnrolling: 2501 location